Prostate cancer prevention and finasteride - Editorial comment - Reply by authors

被引：0

作者：

Thompson, Tim ^{[1
]}

机构：

[1] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA

来源：

JOURNAL OF UROLOGY | 2006年 / 176卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2013 / 2013

页数：1

共 3 条

[1] Prostate-specific antigen velocity and the odds of identifying prostate cancer at biopsy [J].

D'Amico, AV ;

Cullen, J ;

Chen, YM ;

McLeod, DG .

JOURNAL OF UROLOGY, 2006, 175 (04) :169-170

[2] Relationship of PSA velocity and Gleason score in the PLCO cancer screening trial [J].

Grubb, RL ;

Levin, DL ;

Pinsky, PF ;

Mabie, J ;

Riley, TL ;

Reding, DJ ;

Ragard, LR ;

Crawford, ED ;

Andriole, GL .

JOURNAL OF UROLOGY, 2006, 175 (04) :169-169

[3] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].

Thompson, IM ;

Pauler, DK ;

Goodman, PJ ;

Tangen, CM ;

Lucia, MS ;

Parnes, HL ;

Minasian, LM ;

Ford, LG ;

Lippman, SM ;

Crawford, ED ;

Crowley, JJ ;

Coltman, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246

← 1 →